Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Phil Bergman"'
Autor:
Rowena DeJesus, Francesca Moretti, Gregory McAllister, Zuncai Wang, Phil Bergman, Shanming Liu, Elizabeth Frias, John Alford, John S Reece-Hoyes, Alicia Lindeman, Jennifer Kelliher, Carsten Russ, Judith Knehr, Walter Carbone, Martin Beibel, Guglielmo Roma, Aylwin Ng, John A Tallarico, Jeffery A Porter, Ramnik J Xavier, Craig Mickanin, Leon O Murphy, Gregory R Hoffman, Beat Nyfeler
Publikováno v:
eLife, Vol 5 (2016)
SQSTM1 is an adaptor protein that integrates multiple cellular signaling pathways and whose expression is tightly regulated at the transcriptional and post-translational level. Here, we describe a forward genetic screening paradigm exploiting CRISPR-
Externí odkaz:
https://doaj.org/article/740ed0340cbe47708079afcf989db0dd
Autor:
Fergus J. Cameron, Jennifer J Couper, Antony R Lafferty, Elizabeth A. Davis, Maria E. Craig, Karen Demangone, Stephanie R. Johnson, Phil Bergman, Angela Titmuss, Aveni Haynes, Max Bulsara
Publikováno v:
Pediatric Diabetes. 21:707-712
To determine the incidence of childhood onset type 1 diabetes in Australia from 2002 to 2017, and analyze incidence rate trends by calendar year, sex, and age at diagnosis.Children newly diagnosed with type 1 diabetes aged15 years between 2002 and 20
Autor:
Beat Nyfeler, Francesca Moretti, Ioannis Moutsatsos, Zhao B. Kang, Phil Bergman, Xian Zhang, Christophe Antczak
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-6 (2020)
Scientific Reports
Scientific Reports
Gene and compound functions are often interrogated by perturbation. However, we have limited methods to capture associated phenotypes in an unbiased and holistic manner. Here, we describe Fluopack screening as a novel platform enabling the profiling
Autor:
null M. Loredana Marcovecchio, null Marco Colombo, null R. Neil Dalton, null Paul M. McKeigue, null Paul Benitez‐Aguirre, null Fergus Cameron, null Scott T. Chiesa, null Jennifer Couper, null Maria Craig, null Denis Daneman, null Elizabeth Davis, null John Deanfield, null Kim Donaghue, null Timothy W. Jones, null Farid H. Mahmud, null Sally M. Marshall, null H. Andrew W. Neil, null Helen M. Colhoun, null David B. Dunger, null Carlo L. Acerini, null Binu Anand, null Tim Barrett, null Fiona Campbell, null Tim Cheetham, null Chris Cooper, null Ian Doughty, null Julie Edge, null Julian Hamilton‐Shield, null Nick Mann, null Gerry Rayman, null Jonathon M. Robinson, null Michelle Russell‐Taylor, null Vengudi Sankar, null Anne Smith, null Nandu Thalange, null Chandan Yaliwal, null Andrew Cotterill, null Bruce King, null Charles Verge, null Phil Bergman, null Christine Rodda, null Cheril Clarson, null Jacqueline Curtis, null Etienne Sochett, null John Chalmers, null Andrew Collier, null Colin Fischbacher, null Fiona Green, null Robert Lindsay, null John McKnight, null Sandra MacRury, null Colin Palmer, null Alan Patrick, null Donald Pearson, null John Petrie, null Sandeep Thekkepat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::100e7e38a89f4d922c54bd8135a7eaa0
https://doi.org/10.1111/pedi.13095/v2/response1
https://doi.org/10.1111/pedi.13095/v2/response1
Autor:
Maria Kost-Alimova, Lingfei Wang, Kara G. Lassen, Herbert W. Virgin, Shantanu Singh, Jessica W. Luo, Dale R. Balce, Kimberly L. Carey, Lingjia Kong, Nicole A. Renaud, Beat Nyfeler, Ramnik J. Xavier, Geraldine L.C. Paulus, Ianina C. Ferder, Phil Bergman
Publikováno v:
Cell Rep
Transcription factor EB (TFEB) activates lysosomal biogenesis genes in response to environmental cues. Given implications of impaired TFEB signaling and lysosomal dysfunction in metabolic, neurological, and infectious diseases, we aim to systematical
Publikováno v:
Veterinary and Comparative Orthopaedics and Traumatology. 31:A1-A25
Autor:
Geoffrey R Ambler, Charles F. Verge, Phil Bergman, Patricia Crock, Mark Harris, Maria E. Craig, George A. Werther, Ian P. Hughes, Peter Davies, Catherine S. Choong, Elly Scheermeyer
Publikováno v:
Growth Hormone & IGF Research. 34:1-7
Objective Evaluate benefit and risk of low dose growth hormone treatment (GHT, 4.5 mg/m2/week) in very young children with Prader-Willi Syndrome (PWS). Design Prospective longitudinal clinical intervention. Methods We evaluated 31 infants (aged 2–1
Autor:
Leon Murphy, Zhao Kang, Zinger Yang, Debora Bonenfant, Isabelle Claerr, Rowena DeJesus, Carsten Russ, Matthias Mueller, Damien Begue, John S. Reece-Hoyes, Christophe Antczak, Alexandra Graff, Christel Genoud, Beat Nyfeler, Jonathan M. Goodwin, Phil Bergman, Gregory R. Hoffman, Stacie Dodgson, Ramnik J. Xavier, David Marcellin, Francesca Moretti
Publikováno v:
EMBO reports. 19(9)
Autophagy maintains cellular homeostasis by targeting damaged organelles, pathogens, or misfolded protein aggregates for lysosomal degradation. The autophagic process is initiated by the formation of autophagosomes, which can selectively enclose carg
Autor:
Catherine S. Choong, Mieke L van Driel, Maria E. Craig, Elly Scheermeyer, Geoff Ambler, Phil Bergman, Ian P. Hughes, Peter Davies, George A. Werther, Mark Harris, Charles F. Verge, Patricia Crock
Publikováno v:
Journal of Paediatrics and Child Health. 49:1045-1051
Aim The Australian Prader-Willi Syndrome (PWS) database was established to monitor the efficacy and safety of growth hormone (GH) treatment in PWS. This study aims to compare response to GH based on eligibility criteria. Methods Comparative study: 72
Autor:
Zuncai Wang, Walter Carbone, Jennifer Kelliher, Rowena DeJesus, Guglielmo Roma, John S. Reece-Hoyes, Aylwin Ng, Francesca Moretti, Craig Mickanin, Phil Bergman, Alicia Lindeman, Shanming Liu, Gregory R. Hoffman, John Alford, Martin Beibel, Beat Nyfeler, Leon Murphy, Carsten Russ, John A. Tallarico, Gregory McAllister, Judith Knehr, Ramnik J. Xavier, Elizabeth Frias, Jeffery A. Porter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::969d0bf3b951cb089bc956ceb830f70e
https://doi.org/10.7554/elife.17290.014
https://doi.org/10.7554/elife.17290.014